adalimumab-adbm 50 MG/ML [Cyltezo]
RxNorm concept 2640886, branded drug component (sbdc).
- RxCUI
- 2640886
- Term type
- Branded drug component (SBDC)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2640886 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- 0.8 ML adalimumab-adbm 50 MG/ML Prefilled Syringe [Cyltezo] (SBD, constitutes)
- 0.2 ML adalimumab-adbm 50 MG/ML Prefilled Syringe [Cyltezo] (SBD, constitutes)
- 0.4 ML adalimumab-adbm 50 MG/ML Prefilled Syringe [Cyltezo] (SBD, constitutes)
- 0.8 ML adalimumab-adbm 50 MG/ML Auto-Injector [Cyltezo] (SBD, constitutes)
- Cyltezo (BN, has ingredient)
- adalimumab-adbm 50 MG/ML (SCDC, tradename of)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 2640886 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2640886 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2640886. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.